| scholarly article | Q13442814 |
| P2093 | author name string | Constantine A Stratakis | |
| Jeffrey Baron | |||
| James C Reynolds | |||
| Carolyn A Bondy | |||
| Vladimir K Bakalov | |||
| Michael L Chen | |||
| Lauren E Axelrod | |||
| Lori B Hanton | |||
| P2860 | cites work | Bone mineral density in middle-aged women with Turner's syndrome | Q72530645 |
| Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density | Q73180951 | ||
| Phenotypes Associated with SHOX Deficiency | Q77337722 | ||
| Factors associated with the reduction of bone density in patients with gonadal dysgenesis | Q77711849 | ||
| The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator | Q28212674 | ||
| Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome | Q28237330 | ||
| Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded? | Q30668816 | ||
| New approaches for interpreting projected bone densitometry data | Q30982640 | ||
| Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. | Q31068881 | ||
| Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover | Q33398636 | ||
| SHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis | Q33767043 | ||
| The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. | Q34508002 | ||
| Does estimating volumetric bone density of the femoral neck improve the prediction of hip fracture? A prospective study. Study of Osteoporotic Fractures Research Group | Q36711905 | ||
| Proximal femur bone mineral levels of US adults | Q36819045 | ||
| Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy | Q40787666 | ||
| Undiagnosed morbidity in adult women with Turner's syndrome | Q40921492 | ||
| Normal Bone Density of the Wrist and Spine and Increased Wrist Fractures in Girls with Turner’s Syndrome | Q41156179 | ||
| Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients | Q46288017 | ||
| Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men. | Q47219470 | ||
| Morbidity in Turner Syndrome | Q57632257 | ||
| Roentgenographic abnormalities in phenotypic females with gonadal dysgenesis. A comparison of chromatin positive patients and chromatin negative patients | Q68586722 | ||
| Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea | Q71336747 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 259-264 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Bone mineral density and fractures in Turner syndrome. | |
| P478 | volume | 115 |
| Q26747476 | Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies |
| Q58025039 | Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages |
| Q54417723 | Bone mineral density in Turner's syndrome and the influence of pubertal development. |
| Q53166686 | Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: a cross-sectional study using high-resolution-pQCT. |
| Q37978208 | Effects of hypogonadism on bone metabolism in female adolescents and young adults. |
| Q36086963 | Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study |
| Q37973243 | Endocrine diseases, perspectives and care in Turner syndrome |
| Q37139423 | Fracture risk and bone mineral density in Turner syndrome |
| Q64241442 | Glucose Metabolism in Turner Syndrome |
| Q50434604 | Health management of adults with Turner syndrome: an attempt at multidisciplinary medical care by gynecologists in cooperation with specialists from other fields |
| Q39027448 | Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause |
| Q30405632 | Imaging of cardiovascular risk in patients with Turner's syndrome |
| Q41258749 | Impact of Growth Hormone on Adult Bone Quality in Turner Syndrome: A HR-pQCT Study |
| Q36324342 | New issues in the diagnosis and management of Turner syndrome |
| Q84230939 | Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents |
| Q36284471 | Osteoporosis in children and adolescents: etiology and management |
| Q73927539 | Pitfalls in the hunt for osteoporosis |
| Q51496011 | Response to hormonal treatment of young females with primary or very premature ovarian failure. |
| Q37965428 | Sex hormone replacement in Turner syndrome. |
| Q50228090 | The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes. |
| Q92860804 | Turner syndrome: mechanisms and management |
Search more.